Aligning remuneration to our strategic targets
To drive our top priorities which are aligned to delivery of our strategy, we make executives accountable through key performance indicators (KPIs) aligned with our strategy and also align their remuneration with these KPIs.
STRATEGIC TARGETS
ROIC
(US$) >12% through the cycle >2% uplift by 2022
EBIT GROWTH
(US$ real) >5% CAGR through the cycle
ZERO HARM
at all our operations globally
DIVIDEND RETURNS
stepping up pay-out to 40% of Core HEPS (2,5x cover) by 2022 thereafter moving pay-out towards 45% (2,2x cover)
ASPIRATIONAL CULTURE
ensuring engagement and growth of all our employees

OUR TOP PRIORITIES
Our Group top priorities are annually determined by our Joint CEOs in response to the external and internal environments in which we operate and focus the organisation on those key deliverables that will bring us closer to realising our strategy.
Our top priorities for 2019 are:
- pursue zero harm;
- nurture our foundation business and secure license to operate;
- deliver sustainable growth and clarify future investment opportunities;
- build a resilient organisation for the future; and
- drive customer, operational and capital excellence.

Corporate performance targets (CPT) | How does it link to value creation | Weighting % |
2018 Achievement |
Score | 2017 | 2016 | |||||||
Increase in tons produced/head | Through production improvements and an efficient workforce we increase earnings for our shareholders | 25% | 72% | 50% | Achieved stretch target | Achieved stretch target |
|||||||
Growth in attributable earnings | Growth in earnings create value for shareholders and stakeholders | 25% | Below threshold |
0% | Below threshold | Below threshold | |||||||
TSR vs. MSCI World Chemical Index | Total shareholder return (TSR) is a measure of the performance of the Group’s shares over time, and combines both share price appreciation and dividends paid to indicate the total value created to shareholders | 50% | 31st percentile | 0% | Between median and lower quartile | ||||||||
TSR vs. JSE Resi 10 Index | 6th in group | ||||||||||||
TSR vs. MSCI World Energy Index | 52nd percentile | 19% | 47nd percentile | ||||||||||
GEC CPT score for LTI | 69% | 90% | 93% |
Executive Directors
Factors considered in the final determination of the annual STI award. The final individual performance factors (IPFs) are disclosed in a range:
Executive Directors | TGP/Base salary as at 30 June 2018 A |
Target % B |
Group factor % C |
Individual performance factor % range D |
2018 STI value E = AxBxCxD |
||||||
SR Cornell1 | $945 000 | 115% | 63,01 | 100% – 110% | $746 390 | ||||||
B Nqwababa | R10 058 000 | 115% | 63,01 | 100% – 110% | R7 798 350 | ||||||
P Victor | R7 064 900 | 90% | 63,01 | 100% – 110% | R4 407 078 |
- Gross US dollar salary
Remuneration and benefits paid (disclosed in rands) and approved in respect of 2018 for Executive Directors:
Executive Directors | SR Cornell | B Nqwababa | P Victor5 | VN Fakude6 | ||||||||||||
R'000 | 2018 | 2017 | 2018 | 2017 | 2018 | 2017 | 2018 | 2017 | ||||||||
Total salary and benefits1 | 26 431 | 25 833 | 10 341 | 16 678 | 6 948 | 8 611 | – | 4 651 | ||||||||
Annual short-term incentive2 | 10 882 | 9 291 | 7 798 | 7 318 | 4 407 | 4 951 | – | |||||||||
Long-term incentive gains3, 4 | 8 956 | 2 107 | 7 754 | 12 013 | 2 744 | 4 538 | – | 6 312 | ||||||||
Total annual remuneration | 46 269 | 31 231 | 25 893 | 36 009 | 14 099 | 18 100 | – | 10 963 |
- Details of benefits offered on page 34 of the Annual Financial Statements.
- Short-term incentives approved based on the Group results for the 2018 financial year and payable in the 2019 financial year. Incentives are calculated as a percentage of total guaranteed package/base salary as at 30 June 2018.
- Long-term incentives for the 2018 financial year represent the number of units x corporate performance target achieved (2018) x closing share price on 16 August 2018. The actual vesting date for the annual awards made on 21 September 2015 is 21 September 2018. Dividend equivalents accrue at the end of the vesting period, to the extent that the LTI units vest. It represents: number of units awarded x corporate performance targets achieved during financial year 2018 x dividend equivalents up to 21 September 2018.
- Long-term incentive grants made in 2016 vest in 2019 with a vesting result of 69%; 50% of the vested shares are subject to a further holding period of two years.
- Long-term incentives granted in 2016 to Mr P Victor, whilst he was a Senior Vice President will vest in 2019.
- Ms Fakude resigned from the Group with effect from 31 December 2016.
Details of long-term incentives and share appreciation rights on page 34 of the Annual Financial Statements.
Prescribed Officers
Factors considered in the final determination of the annual STI award. The final individual performance factors (IPFs) are disclosed in a assignment range:
Prescribed Officers | TGP/Base salary/ Net indicative assignment salary as at 30 June 2018 A |
Target % B |
Group factor % C |
Individual performance factor % range4 D |
2018 STI value E = AxBxCxD |
|||||
FR Grobler1 | €286 032 | 75% | 63,01% | 100% - 110% | €141 930 | |||||
JR Harris2 | €350 000 | 75% | 63,01% | 90% - 99% | €133 247 | |||||
VD Kahla | R6 452 180 | 75% | 63,01% | 100% - 110% | R3 201 596 | |||||
BE Klingenberg | R7 701 570 | 75% | 63,01% | 100% - 110% | R3 639 569 | |||||
CK Mokoena | R5 325 000 | 75% | 63,01% | 90% - 99% | R2 390 639 | |||||
M Radebe | R5 607 886 | 75% | 63,01% | 90% - 99% | R2 517 639 | |||||
CF Rademan3 | R6 390 474 | 75% | 63,01% | 90% - 99% | R905 993 | |||||
SJ Schoeman1 | $367 752 | 75% | 63,01% | 90% - 99% | $165 101 |
- STI based on Net Indicative Assignment Salary (NIAS) and net STI value.
- Pro rata STI value for the period 7 August 2017 to 30 June 2018, STI based on gross salary and NIAS. STI indicated as a gross value.
- Mr Rademan retired with effect from 31 October 2017.
- Actual score determined by performance against individual scorecard, in a range of 0% – 150%.
Remuneration and benefits paid (disclosed in rands) and approved in respect of 2018 for Prescribed Officers:
Prescribed Officers | FR Grobler | JR Harris | VD Kahla | BE Klingenberg | ||||||||||||
R'000 | 2018 | 2017 | 2018 | 2017 | 2018 | 2017 | 2018 | 2017 | ||||||||
Total salary and benefits1 | 10 567 | 7 832 | 11 287 | – | 6 804 | 6 370 | 8 002 | 7 410 | ||||||||
Annual short-term incentive2 | 4 486 | 3 515 | 2 844 | – | 3 202 | 3 292 | 3 640 | 3 929 | ||||||||
Long-term incentive gains3, 4 | 5 234 | 3 094 | – | – | 6 203 | 3 713 | 7 173 | 3 713 | ||||||||
Total annual remuneration | 20 287 | 14 441 | 14 131 | – | 16 209 | 13 375 | 18 815 | 15 052 |
Prescribed Officers | CK Mokoena | M Radebe | CF Rademan5 | SJ Schoeman | ||||||||||||
R'000 | 2018 | 2017 | 2018 | 2017 | 2018 | 2017 | 2018 | 2017 | ||||||||
Total salary and benefits1 | 9 339 | 6 378 | 5 627 | 5 394 | 2 159 | 6 319 | 11 463 | 10 118 | ||||||||
Annual short-term incentive2 | 2 391 | 1 137 | 2 518 | 2 575 | 906 | 3 314 | 3 774 | 3 366 | ||||||||
Long-term incentive gains3, 4 | – | – | 5 428 | 3 713 | 6 591 | 4 538 | 9 072 | 3 094 | ||||||||
Total annual remuneration | 11 730 | 7 515 | 13 573 | 11 682 | 9 656 | 14 171 | 24 309 | 16 578 |
- Details of benefits offered on page 35 of the Annual Financial Statements.
- Short-term incentives approved based on the Group results for the 2018 financial year and payable in the 2019 financial year. Incentives are calculated as a percentage of total guaranteed package/base salary/net indicative expatriate salary as at 30 June 2018.
- Long-term incentives for the 2018 financial year represent the number of units x corporate performance target achieved (2018) x closing share price on 16 August 2018. The actual vesting date for the annual awards made on 21 September 2015 is 21 September 2018. Dividend equivalents accrue at the end of the vesting period, to the extent that the LTI units vest. It represents: number of units awarded x corporate performance targets achieved during financial year 2018 x dividend equivalents up to 21 September 2018.
- Long-term incentive grants made in 2016 vests in 2019 with a vesting result of 69%, 50% of the vested shares are subject to a further holding period of two years.
- Mr Rademan retired with effect from 31 October 2017. A service penalty of 15% was applied on Long-term incentives.
Details of long-term incentives and share appreciation rights on page 36 and 37 of the Annual Financial Statements.
Beneficial shareholding
The aggregate beneficial shareholding at 30 June 2018 of the directors of the company and the Prescribed Officers and their associates (none of whom have a holding greater than 1%) in the issued ordinary share capital of the company are detailed in the following tables:
2018 | 2017 | |||||||||||
Beneficial shareholding | Direct beneficial |
Indirect beneficial2 |
Total beneficial shareholding |
Direct beneficial |
Indirect beneficial2 |
Total beneficial shareholding |
||||||
Executive Directors | ||||||||||||
SR Cornell3 | – | – | – | 19 000 | – | 19 000 | ||||||
VN Fakude4 | – | – | – | 4 269 | – | 4 269 | ||||||
B Nqwababa5 | 13 003 | – | 13 003 | – | – | – | ||||||
Non-executive Directors | ||||||||||||
MBN Dube 6, 7 | 24 | 233 | 257 | – | – | – | ||||||
NNA Matyumza7 | 6 | 56 | 62 | – | 55 | 56 | ||||||
IN Mkhize 7, 8 | 1 844 | 18 435 | 20 279 | – | 18 435 | 18 435 | ||||||
ZM Mkhize7 | 181 | 330 | 511 | – | 330 | 330 | ||||||
Prescribed Officers | ||||||||||||
FR Grobler9 | 13 500 | – | 13 500 | 13 500 | – | 13 500 | ||||||
CF Rademan9, 10 | 1 300 | – | 1 300 | 4 000 | – | 4 000 | ||||||
M Radebe11 | 5 299 | 2 850 | 8 149 | – | 3 357 | 3 357 | ||||||
Total | 35 157 | 21 904 | 55 061 | 40 769 | 22 178 | 62 947 |
- There has been no change in the above shareholding between the end of the financial year and the date of approval of the Annual Financial Statements. Interest in Employee Share Savings Trust and Long-term Incentives excluded.
- Sasol Inzalo Public (RF) Limited shares.
- Direct beneficial shareholding comprise of American Depository Receipts.
- Ms Fakude resigned with effect from 31 December 2016, no disclosure required for 2018.
- Direct beneficial shareholding comprise of Sasol ordinary shares.
- Appointed with effect from 1 April 2018.
- Direct beneficial shareholding comprise of Sasol BEE ordinary shares.
- Resigned with effect from 17 November 2017.
- Direct beneficial shareholding comprise of Sasol ordinary shares.
- Retired with effect from 31 October 2017.
- Direct beneficial shareholding comprise of 5 014 Sasol ordinary shares and 285 Sasol BEE ordinary shares.
Non-executive Directors' remuneration for the year was as follows:
Board meeting fees1 |
Lead Independent Director fees1 |
Committee fees1 |
Ad hoc or special meeting1 |
Total 20181 |
Total 2017 |
|||||||
Non–executive Directors | R'000 | R'000 | R'000 | R'000 | R'000 | R'000 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
MSV Gantsho (Chairman) | 5 827 | – | – | – | 5 827 | 4 900 | ||||||
HG Dijkgraaf 2, 3 (Lead Independent Director) | 1 594 | 558 | 632 | 21 | 2 805 | 3 567 | ||||||
MJN Njeke 4 (Lead Independent Director) | 826 | 49 | 361 | 138 | 1 374 | 1 039 | ||||||
C Beggs | 826 | – | 722 | 207 | 1 755 | 1 301 | ||||||
MJ Cuambe 2 | 1 950 | – | 481 | 42 | 2 473 | 2 437 | ||||||
MDN Dube 2,5 | 505 | – | 124 | – | 629 | – | ||||||
M Flöel 2,6 | 951 | – | 131 | – | 1 082 | – | ||||||
GMB Kennealy | 826 | – | 361 | 24 | 1 211 | 165 | ||||||
NNA Matyumza | 826 | – | 516 | 183 | 1 525 | 1 175 | ||||||
IN Mkhize 7 | 314 | – | 391 | 72 | 777 | 1 410 | ||||||
ZM Mkhize | 743 | – | 179 | 21 | 943 | 819 | ||||||
MEK Nkeli | 826 | – | 382 | 48 | 1 256 | 165 | ||||||
PJ Robertson 2 | 1 950 | – | 869 | 21 | 2 840 | 3 140 | ||||||
S Westwell 2 | 1 950 | – | 1 313 | 63 | 3 326 | 2 961 | ||||||
Total | 19 914 | 607 | 6 462 | 840 | 27 823 | 23 079 |
- Fees include value added tax (VAT) paid from 1 June 2017.
- Board and committee fees paid in US dollars.
- Mr Dijkgraaf retired from the Board on 30 April 2018.
- Mr Njeke was appointed as Lead Independent Director on 1 May 2018.
- Ms Dube appointed effective 1 April 2018.
- Dr Flöel appointed effective 1 January 2018.
- Ms Mkhize retired from the Board on 17 November 2017.